Pricing Log in Create free account

C4 Therapeutics, Inc. (CCCC) vs Turn Therapeutics Inc. (TTRX)

C4 Therapeutics, Inc. and Turn Therapeutics Inc. are both Biotechnology companies. C4 Therapeutics, Inc. and Turn Therapeutics Inc. are of similar size ($345.3M and $342.0M). Turn Therapeutics Inc. has the higher net margin (0.00% vs −289.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, C4 Therapeutics, Inc. leads on 6 and Turn Therapeutics Inc. on 6.

Valuation

Metric CCCC TTRX Biotechnology median
P/E n/m n/m 8.50
P/S 10.33 n/m 9.71
P/B 1.46 458.38 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 3.63 n/m 9.21
Earnings yield (36.10%) (2.74%) (33.15%)
Free cash flow yield (23.59%) (1.42%) (25.50%)

Profitability

Metric CCCC TTRX Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (318.97%) 0.00% 0.00%
Net margin (289.44%) 0.00% 0.00%
Free cash flow margin (243.71%) 0.00% 0.00%
Return on equity (48.14%) (3,315.33%) (56.36%)
Return on assets (30.92%) (99.59%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CCCC TTRX Biotechnology median
Revenue growth (TTM) 2.33% — 6.02%
EPS growth (last fiscal year) 16.45% (80.72%) 30.26%
Revenue growth, 5-year CAGR 1.61% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CCCC TTRX Biotechnology median
Debt to equity 0.00 8.83 0.00
Current ratio 5.45 1.19 4.72
Net debt to EBITDA 2.14 0.96 0.96

Dividend

Metric CCCC TTRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CCCC TTRX Biotechnology median
Market cap 342.01m 345.25m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack